Skip to content
Clinical Trials – home

Centrum Diagnostyczno Terapeutyczne Medicus Sp. z o.o.

Research site

Poland Ul. Lesna 8, 59-300 Lubin, Poland

  • 1 trial recruiting
  • Asthma · Chronic obstructive pulmonary disease · Conjunctivitis allergic
  • Adult patients

About Specializations

Centrum Diagnostyczno Terapeutyczne Medicus Sp. z o.o. in Lubin, Poland specialises in clinical trials of conditions such as Asthma, Chronic obstructive pulmonary disease, Conjunctivitis allergic, Rhinitis allergic, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

The research at this centre targets Allergic Rhinitis/Rhinoconjunctivitis caused by House Dust Mite allergy, aiming to improve patient symptoms through targeted immunotherapy.

  • Evaluation of a high‑potency mite extract for subcutaneous immunotherapy
  • Assessment of symptom score improvements in HDM‑induced allergy

Centrum Diagnostyczno Terapeutyczne Medicus in Lubin, Poland, conducts these patient‑focused studies.

Respiratory Tract Diseases

Trials address Chronic Obstructive Pulmonary Disease by testing a triple therapy inhaler regimen to reduce severe cardiopulmonary events.

  • Comparison of triple inhaler regimen versus dual bronchodilator in COPD
  • Evaluation of cardiopulmonary safety and efficacy outcomes

The site’s work in Lubin supports advances in respiratory care for the local community.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Lesna 859-300 LubinPoland
Recruiting now
1 trial
Conditions studied
4

More sites in LubinPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Conjunctivitis allergic+1

Not recruiting

Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Aluminium Hydroxide
  • Sponsor:HAL Allergy B.V.

Asthma

Not recruiting

Study on the Effects of Povorcitinib for Adults with Moderate to Severe Asthma Not Well Controlled

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.

Asthma

Not recruiting

Study on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Rapt Therapeutics Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.